Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study

OBJECTIVE To examine the effects of crossing over from optimized multiple daily injection (MDI) therapy to sensor-augmented pump (SAP) therapy for 6 months, and the effects of 18 months’ sustained use of SAP. RESEARCH DESIGN AND METHODS The 6-month, single-crossover continuation phase of Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) provided SAP therapy to 420 subjects who completed the 1-year randomized study. The primary outcome was change in A1C in the crossover group. RESULTS A1C values were initially lower in the continuing-SAP group than in the crossover group (7.4 vs. 8.0%, P < 0.001). A1C values remained reduced in the SAP group. After 3 months on the SAP system, A1C decreased to 7.6% in the crossover group (P < 0.001); this was a significant and sustained decrease among both adults and children (P < 0.05). CONCLUSIONS Switching from optimized MDI to SAP therapy allowed for rapid and safe A1C reductions. Glycemic benefits of SAP therapy persist for at least 18 months.

• Publication year

  2011

• Venue

  Diabetes Care

• Publication date

  2011-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc11-1248PMID 21933908PMCID 3198292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of sensor‐augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study

  2012cited by this paper
• Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump

  2011cited by this paper
• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

  2010cited by this paper
• STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects

  2010cited by this paper
• The Use of an Energy Monitor in the Management of Diabetes: A Pilot Study

  2009cited by this paper
• Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes

  2009cited by this paper
• Can We Really Close the Loop and How Soon? Accelerating the Availability of an Artificial Pancreas: A Roadmap to Better Diabetes Outcomes

  2009cited by this paper
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

  2005cited by this paper

• Comparative Study of Glycemic Control and Treatment Satisfaction in Patients With Type 1 Diabetes on Sensor-Augmented Insulin Pump, Insulin Pump, and Multiple Daily Insulin Injections: A Cross-Sectional Study

  2025cites this paper
• Continuous Glucose Monitoring Frequency and Glycemic Control in People With Type 2 Diabetes

  2025cites this paper
• Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients

  2025cites this paper
• The Impact of Expanding Diabetes Services on the Trend of Glycemic Control in Children and Adolescents with Type 1 Diabetes

  2024cites this paper
• The introduction of new technologies for insulin therapy and glycemic control in clinical practice in the period 2016-2023, and their impact on achieving treatment targets in children with type 1 diabetes mellitus

  2024cites this paper
• Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study

  2024cites this paper
• Evaluating the Impact of Continuous Glucose Monitoring on Erectile Dysfunction in Type 1 Diabetes: A Focus on Reducing Glucose Variability and Inflammation

  2024cites this paper
• Grossesse chez la patiente atteinte d’un diabète de type 1 : résultats métaboliques et obstétricaux avant l’utilisation de la boucle fermée hybride

  2024cites this paper
• Glycaemic control and novel technology management strategies in pregestational diabetes mellitus

  2023cites this paper
• Long-Term Benefits of an Integrated Continuous Glucose Monitoring and Insulin Pump System for Emergency Admissions, Hospitalization, and Metabolic Control in a Cohort of People With Diabetes: Retrospective Cohort Study

  2023cites this paper
• MESA 2: INNOVACIONES TECNOLÓGICAS EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1

  2023influential citation
• The Application of Digital Health in Diabetes Management

  2023cites this paper
• Guideline Development for Medical Device Technology: Issues for Consideration

  2022cites this paper
• Long-term Bene�ts in Emergency Admissions, Hospitalization and Metabolic Control of an Integrated Continuous Glucose Monitoring and Insulin Pump System in a Cohort of Diabetic Patients

  2022cites this paper
• Diabete hi-tech

  2022cites this paper
• RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis

  2022cites this paper
• Feasibility of the Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitor (IDEAL CGM) Training and Follow-Up Support Intervention: Randomized Controlled Pilot Study

  2021cites this paper
• Continuous glucose monitoring systems in well-controlled children with type 1 diabetes mellitus

  2021cites this paper
• Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes

  2021cites this paper
• Mini Review ISLET Neogenesis in Man Without the Need for Transplants

  2021cites this paper
• Correlates of Continuous Glucose Monitoring Use Trajectories in Children and Adolescents with Type 1 Diabetes

  2021cites this paper
• Automated Insulin Delivery: Easy Enough to Use in Primary Care?

  2020cites this paper
• Shaping Workflows in Digital and Remote Diabetes Care During the COVID-19 Pandemic via Service Design: Prospective, Longitudinal, Open-label Feasibility Trial

  2020cites this paper
• Diabetes mellitus type 1 in childhood

  2020cites this paper
• Physiological principles of Starling-like control of rotary ventricular assist devices

  2020cites this paper
• Continuous Glucose Monitoring: the achievement of 100 years of innovation in diabetes technology.

  2020cites this paper
• Part I: Continuous glucose monitoring systems

  2020cites this paper
• Part II: Subcutaneous insulin infusion devices

  2020cites this paper
• Setting limits on neural network's predictive capacity in T1D blood glucose concentration

  2020cites this paper
• Clinical Studies on Efficacy of Continuous Glucose Monitoring

  2020cites this paper
• A systematic review on clinical implication of continuous glucose monitoring in diabetes management

  2020cites this paper
• The Development and Psychometric Validation of the Diabetes Impact and Device Satisfaction Scale for Individuals with Type 1 Diabetes

  2020cites this paper
• Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.

  2020cites this paper
• High Prevalence of Skin Reactions Among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium

  2020cites this paper
• Using the Novel Approach of an Artificial Pancreas to Manage Type 1 Diabetes Mellitus in Pregnancy

  2019cites this paper
• Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Update 2019)

  2019cites this paper
• Insulinpumpentherapie bei Kindern , Jugendlichen und Erwachsenen ( Update 2019 )

  2019cites this paper
• Patient Perception and Satisfaction With Insulin Pump System: Pilot User Experience Survey

  2019cites this paper
• Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes

  2019cites this paper
• Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

  2019cites this paper
• Traitement par pompe à insuline externe chez l’adulte

  2019cites this paper
• Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII)

  2019cites this paper
• Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK

  2019cites this paper
• Human Factors Associated with Continuous Glucose Monitor Use in Patients with Diabetes: A Systematic Review

  2019cites this paper
• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

  2019cites this paper
• Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months

  2019cites this paper
• Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy

  2018cites this paper
• Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results

  2018cites this paper
• A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II

  2018cites this paper
• Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings

  2018cites this paper
• Technology in the management of type 1 diabetes mellitus — current status and future prospects

  2018cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies

  2018influential citation
• Predicting Blood Glucose with an LSTM and Bi-LSTM Based Deep Neural Network

  2018cites this paper
• In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes

  2018cites this paper
• Avancées technologiques et traitement du diabète

  2018cites this paper
• Calibration of continuous glucose monitoring sensors by time-varying models and Bayesian estimation

  2018cites this paper
• of Diabetes and Treatment Islet Neogenesis Therapy from Endogenous Pancreatic Stem Cells without Transplantation: Will Type 1 and Type 2 Diabetes Soon be Diseases of the Past?

  2017cites this paper
• Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes

  2017cites this paper
• Kontinuierliche Glukosemessung (CGM) bei Erwachsenen

  2017cites this paper
• Continuous glucose monitoring: A review of the technology and clinical use.

  2017cites this paper
• Inflammatory mechanisms associated with type 1 diabetes mellitus and oral diseases

  2017cites this paper
• Automatic adaptation of basal therapy for Type 1 diabetic patients: A Run-to-Run approach

  2017cites this paper
• Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes

  2017cites this paper
• Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist

  2017cites this paper
• Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes

  2017cites this paper
• Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

  2017cites this paper
• A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes

  2017cites this paper
• Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen

  2016cites this paper
• Treatment of patients with type 1 diabetes – Insulin pumps or multiple injections?

  2016cites this paper
• Model-based analysis of user behaviors in medical Cyber-Physical Systems

  2016cites this paper
• Use of medicines and devices by adults in the management of Type 2 diabetes in Kuwait

  2016cites this paper
• Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study

  2016cites this paper
• Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies

  2016cites this paper
• Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons

  2016cites this paper
• Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes

  2016cites this paper
• Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?

  2016cites this paper
• Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

  2016cites this paper
• en representación del Grupo de Trabajo de Nuevas Tecnologías de la Sociedad Espa˜ de Diabetes (SED), el Grupo de Diabetes de la Sociedad Espade Endocrinología y Nutrición (SEEN) y la Sociedad Espade Endocrinología Pediátrica (SEEP)

  2016cites this paper
• Diabetes Technology

  2016cites this paper
• Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.

  2016cites this paper
• CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

  2016cites this paper
• Sensorstyrd pumpterapi : En studie om effekt på glykerat hemoglobin vid Diabetes Mellitus typ 1

  2016cites this paper
• Kontinuierliche Glukosemessung im Alltag

  2016cites this paper
• Nationwide reduction in the frequency of severe hypoglycemia by half

  2015cites this paper
• Nationwide reduction in the frequency of severe hypoglycemia by half

  2015cites this paper
• Utilization and costs of prescription medication in patients with type 1 diabetes: Impact of diabetic kidney disease

  2015cites this paper
• Implantable pumps and artificial and bio‐artificial pancreas system

  2015cites this paper
• Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the STAR 3 study.

  2015cites this paper
• Impact of new technologies on diabetes care.

  2015cites this paper
• High Reported Treatment Satisfaction in People With Type 1 Diabetes Switching to Latest Generation Insulin Pump Regardless of Previous Therapy

  2015cites this paper
• Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus

  2015cites this paper
• Sensor-augmented pump and multiple daily injection therapy in the United States and Canada: post-hoc analysis of a randomized controlled trial.

  2015cites this paper
• Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia

  2015cites this paper
• A Data-Driven Behavior Modeling and Analysis Framework for Diabetic Patients on Insulin Pumps

  2015cites this paper
• A perspective of sensor-augmented insulin pump therapy in the treatment of type 1 diabetes.

  2015cites this paper
• Wearable systems and mobile applications for diabetes disease management

  2014cites this paper
• Type 1 diabetes.

  2014cites this paper
• Position statement on efficiency of technologies for diabetes management.

  2014cites this paper
• Wearable systems and mobile applications for diabetes disease management

  2014cites this paper
• AACE/ACE Consensus Statement

  2014cites this paper